Ameritas Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,275
| Closed | -$167K | – | 1685 |
|
|
2023
Q1 | $167K | Buy |
+2,275
| New | +$167K | 0.01% | 822 |
|
|
2022
Q4 | – | Sell |
-3,727
| Closed | -$200K | – | 897 |
|
|
2022
Q3 | $200K | Hold |
3,727
| – | – | 0.01% | 717 |
|
|
2022
Q2 | $207K | Hold |
3,727
| – | – | 0.01% | 737 |
|
|
2022
Q1 | $262K | Hold |
3,727
| – | – | 0.01% | 707 |
|
|
2021
Q4 | $359K | Buy |
+3,727
| New | +$359K | 0.01% | 597 |
|